← Leaderboards
Yangmei Li
Brilliant Biosciences, Inc.
$783,746
Attributed
$783,746
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $225K · FY2018–21$250K$187.5K$125K$62.5K$0
'18
'19
'20
'21
Funding mix
By agency
NIH$783,746 · 2
By mechanism
P20$558,749 · 1
R41$224,997 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Age Related Neurodegeneration”
- Maria C Carrillo · Indiana University Indianapolis$19,221,863
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$13,071,751
- Jessica Elaine Young · University Of Washington$6,465,593
- Charles Bernick · Athira Pharma, Inc.$6,312,103
- Hans Joerg Moebius · Athira Pharma, Inc.$6,312,103
- Yin Shen · University Of California, San Francisco$6,202,280
Research focus
Age Related NeurodegenerationAtp PhosphohydrolaseBindingCancer Cell LineChemical SynthesisCocaineCrystallizationCytokineDesignDockingDrug KineticsFoundationsFunctional DisorderFutureHelicaseHepatitis CHiv-Associated Neurocognitive DisorderHiv/HcvHiv InfectionsInflammationInhibitor/AntagonistInstructionInterruptionIn Vitro
Grant awards (4)
Design, Synthesis and Identification of Potent DDX3 Inhibitors with Drug-like Profiles$223,500
P20 · FY2021 · GM · contact PI
Design, Synthesis and Identification of Potent DDX3 Inhibitors with Drug-like Profiles$223,499
P20 · FY2020 · GM · contact PI
Design, Synthesis and Identification of Potent DDX3 Inhibitors with Drug-like Profiles$111,750
P20 · FY2019 · GM · contact PI
TFEB Activator for Alzheimerâs Disease Therapy$224,997
R41 · FY2018 · AG · contact PI